The Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Catheter-Related Bladder Discomfort in Patients Undergoing Transurethral Resection of the Prostate
Table 5
Serum concentration of biochemical indicators.
TEAS group (n = 35)
Control group (n = 35)
T0
T4
T5
T9
T10
T0
T4
T5
T9
T10
1L-1β (ng/ml)
0.1 (0.6)
0.1 (0.1)
0.1 (0.0)
0.1 (0.0)
0.1 (0.0)
0.1 (0.1)
0.1 (0.1)
0.1 (0.1)
0.1 (0.0)
0.1 (0.0)
TNF-α (pg/ml)
0.2 (0.2)
0.2 (0.2)
0.2 (0.2)
0.2 (0.2)
0.2 (0.2)
0.2 (0.2)
0.2 (0.2)
0.2 (0.1)
0.2 (0.1)
0.2 (0.1)
Epinephrine (ng/ml)
0.2 (0.2)
0.2 (0.2)
0.2 (0.2)
0.2 (0.1)
0.2 (0.1)
0.2 (0.3)
0.2 (0.3)
0.2 (0.3)
0.2 (0.3)
0.2 (0.3)
Blood glucose (mmol/L)
5.3 (0.6)
5.2 (0.5)
5.5 (1.0)
5.6 (1.2)
5.7 (1.0)
5.3 (0.5)
5.3 (0.5)
6.2 (2.4)
6.3 (2.4)
5.9 (1.9)
Blood lactic acid (mmol/L)
0.9 (0.4)
1.0 (0.4)
1.0 (0.4)
1.0 (0.4)
1.0 (0.7)
1.0 (0.3)
1.0 (0.3)
1.1 (0.3)
1.1 (0.4)
1.1 (0.6)
TEAS: transcutaneous electrical acupoint stimulation.T0: before anesthesia; T4: 30 minutes after surgery; T5: at the end of surgery; T9: at the time out of PACU. IL-1β: interleukin-1; TNF-α: tumor necrosis-α. vs. T4.
